Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
04/2001
04/03/2001US6211435 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use
04/03/2001US6211434 For the in vivo detoxification or degradation of fumonisin or its hydrolysis product; used to transform plant cells normally susceptible to fusarium or other toxin-producing fungus infection
04/03/2001US6211351 For introduction of genetic changes in eukaryotic cells
04/03/2001US6211339 Apoptosis polypeptide
04/03/2001US6211338 Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide
04/03/2001US6211336 Ataxia-telangiectasia gene
04/03/2001US6211142 Compositions comprising gas6 polypeptides and articles of manufacture comprising the same
04/03/2001US6211134 Mutant α-amylase
04/03/2001US6210968 DNA molecules encoding pgp3 protein from Chlamydia trachomatis
04/03/2001US6210951 GMP synthetase and gene coding for the same
04/03/2001US6210949 Nucleotide sequences coding tumor suppressor proteins; for the diagnosis and treatment of cancer; anticarcinogenic agents
04/03/2001US6210948 Nucleotide sequence coding a bacterial protein; for utilization in bioreactors
04/03/2001US6210945 Method for cloning and producing the RsaI restriction endonuclease in E. coli and purification of the recombinant RsaI restriction endonuclease
04/03/2001US6210942 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use
04/03/2001US6210935 Dna from streptomyces which codes for polypeptide involved in biosynthesis; probing libraries; polymerase chain reaction amplifications; inhibiting biosynthesis; transformed host organisms
04/03/2001US6210934 Transaminase from escherichia coli; for efficient production of l-2-amino-4-methylphosphinobutyric acid
04/03/2001US6210933 Amino acid sequence; for adding sialic acids to glycoproteins, glycolipids, and other acceptor molecules
04/03/2001US6210930 Process for preparing doxorubicin
04/03/2001US6210925 Direct expression of peptides into culture media
04/03/2001US6210905 Antigen binding region of antibody which binds epitope of defined amino acid sequence; for detecting the protein in biological sample
04/03/2001US6210675 Post-transfusional non-a non-b hepatitis viral polypeptide
04/03/2001US6210674 GreA from Staphylococcus aureus
04/03/2001US6210579 Bioremediation of pollutants with butane-utilizing bacteria
04/03/2001CA2060534C Microbiological process for the production of 6-hydroxypicolinic acid
04/01/2001CA2321597A1 Cellulose produced by filamentous fungi
03/2001
03/30/2001WO2003044525A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
03/30/2001WO2003042411A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
03/30/2001WO2002090588A1 Interfering with telomere maintenance in treatment of diseases
03/30/2001CA2283538A1 New hev antigenic peptide and methods
03/29/2001WO2001021828A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1
03/29/2001WO2001021825A2 Novel enzymes which dehydrate glycerol
03/29/2001WO2001021818A1 Lactobacillus delbruckii strain and its use for screening plasmids
03/29/2001WO2001021815A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use
03/29/2001WO2001021814A1 Heparanase-2, a member of the heparanase protein family
03/29/2001WO2001021813A1 Method and compositions for improved polynucleotide synthesis
03/29/2001WO2001021812A1 Phosphatases which activate map kinase pathways
03/29/2001WO2001021809A2 Stachybotrys phenol oxidizing enzyme
03/29/2001WO2001021808A2 Lactic acid bacteria transformed to be provided with respiratory metabolism
03/29/2001WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof
03/29/2001WO2001021799A1 Traf4 associated cell cycle proteins, compositions and methods of use
03/29/2001WO2001021797A1 Rgs10b, a g-protein regulator expressed in osteoclasts
03/29/2001WO2001021796A2 Gl50 molecules and uses therefor
03/29/2001WO2001021787A1 Polypeptide humanin inhibiting nerve cell death
03/29/2001WO2001021786A1 Method of screening disease depressant gene
03/29/2001WO2001021784A2 Pcna-associated cell cycle proteins, compositions and methods of use
03/29/2001WO2001021774A1 Novel transaldolase gene
03/29/2001WO2001021772A2 Methods and microorganisms for production of panto-compounds
03/29/2001WO2001021771A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
03/29/2001WO2001021764A1 A pcra helicase of staphylococcus aureus
03/29/2001WO2001021763A1 Novel baker's yeast and doughs containing the same
03/29/2001WO2001021759A2 Method for cultivating cells, a membrane module, utilization of a membrane module and reaction system for cultivation of said cells
03/29/2001WO2001021662A1 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium
03/29/2001WO2001021658A1 32 human secreted proteins
03/29/2001WO2001021657A1 Novel protein, gene encoding the same and method of utilization thereof
03/29/2001WO2001021654A2 Syk kinase-associated cell cycle proteins, compositions and methods of use
03/29/2001WO2001021215A1 Cell based assay
03/29/2001WO2001021202A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells
03/29/2001WO2001021200A1 Oral recombinant lactobacilli vaccines
03/29/2001WO2001000843A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins
03/29/2001WO2000077026A8 49 human secreted proteins
03/29/2001WO2000032775A9 Pth1r and pth3r receptors
03/29/2001WO2000012741A9 Inducible expression system
03/29/2001WO1999013083A9 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth
03/29/2001US20010000075 Neurotactin and uses therefor
03/29/2001DE19946047A1 Proteinproduktion mit Ashbya gossypii Protein production using Ashbya gossypii
03/29/2001DE19944870A1 Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium Signal sequences for preparing Leu-hirudin by E. coli via secretion into the culture medium
03/29/2001DE19937548A1 Ein- oder mehrzellige Organismen zur Herstellung von Riboflavin Mono- or multicellular organisms for the production of riboflavin
03/29/2001CA2387695A1 A novel member of the heparanase protein family
03/29/2001CA2385879A1 Traf4 associated cell cycle proteins, compositions and methods of use
03/29/2001CA2385783A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1
03/29/2001CA2385552A1 Phosphatases which activate map kinase pathways
03/29/2001CA2385497A1 Methods and microorganisms for production of panto-compounds
03/29/2001CA2385480A1 32 human secreted proteins
03/29/2001CA2385460A1 Rgs10b, a g-protein regulator expressed in osteoclasts
03/29/2001CA2385428A1 Novel pcna-associated cell cycle proteins, compositions and methods of use
03/29/2001CA2385362A1 Method for cultivating cells, a membrane module, utilization of a membrane module and reaction system for cultivation of said cells
03/29/2001CA2385359A1 Lactic acid bacteria transformed to be provided with respiratory metabolism and yeast containing said bacteria
03/29/2001CA2385334A1 Novel syk kinase-associated cell cycle proteins, compositions and methods of use
03/29/2001CA2385257A1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
03/29/2001CA2385235A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use
03/29/2001CA2383591A1 Cell based assay
03/29/2001CA2383462A1 Therapeutic methods and compounds
03/29/2001CA2383433A1 Oral recombinant lactobacilli vaccines
03/29/2001CA2319213A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
03/28/2001EP1087017A2 The cytoplasmic inhibition of gene expression
03/28/2001EP1087015A2 Cloning and uses of a novel nucleotide sequence coding for glucose-6-phosphate isomerase (gpi) from bacteria
03/28/2001EP1087014A1 Hog cholera virus vaccine and diagnostic
03/28/2001EP1087013A2 Immunoglobulins devoid of light chains
03/28/2001EP1086252A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
03/28/2001EP1086241A1 Non-viable cell preparation and assay reagent
03/28/2001EP1086237A2 Expression cassette for transformation comprising a modified viral sequence driven by a suitable promoter
03/28/2001EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof
03/28/2001EP1086225A2 Human tumour-derived polypeptide hormone phosphatonin
03/28/2001EP1086222A2 Cell cycle regulation proteins
03/28/2001EP1086221A2 Truncated apaf-1 and methods of use thereof
03/28/2001EP1086218A2 Genes and gene expression products that are differentially regulated in prostate cancer
03/28/2001EP1086215A2 Preparation and use of superior vaccines
03/28/2001EP1086211A2 Novel mannanases
03/28/2001EP1086210A1 Novel mannanases
03/28/2001EP1086209A2 Fy7 polymerase